Cancer Drugs Market Report

1 Report Overview

• 1.1 Product Definition and Scope

• 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Drugs Market

• 1.3 Market Segment by Type

• 1.3.1 Japan Cancer Drugs Market Size and Growth Rate of Breast Cancer from 2014 to 2026

• 1.3.2 Japan Cancer Drugs Market Size and Growth Rate of Blood Cancer from 2014 to 2026

• 1.3.3 Japan Cancer Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2014 to 2026

• 1.3.4 Japan Cancer Drugs Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

• 1.3.5 Japan Cancer Drugs Market Size and Growth Rate of Skin Cancer from 2014 to 2026

• 1.3.6 Japan Cancer Drugs Market Size and Growth Rate of Lung Cancer from 2014 to 2026

• 1.4 Market Segment by Application

• 1.4.1 Japan Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2014 to 2026

• 1.4.2 Japan Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

• 1.4.3 Japan Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

• 1.4.4 Japan Cancer Drugs Market Size and Growth Rate of Hormone Therapy from 2014 to 2026

• 1.5 Market Segment by Regions

• 1.5.1 Hokkaido Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.2 Tohoku Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.3 Kanto Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.4 Chubu Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.5 Kinki Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.6 Chugoku Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.7 Shikoku Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.8 Kyushu Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

• 2.1 Market Trends and Dynamics

• 2.1.1 Market Challenges and Restraints

• 2.1.2 Market Opportunities and Potentials

• 2.1.3 Mergers and Acquisitions

• 2.2 Competitive Landscape Analysis

• 2.2.1 Industrial Concentration Analysis

• 2.2.2 Porter's Five Forces Analysis of the Industry

• 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Cancer Drugs Market by Types

• 3.1 Products Development Trends of Different Types

• 3.2 Commercial Products Types of Major Vendors

• 3.3 Competitive Landscape Analysis of Different Types

• 3.4 Market Size of Cancer Drugs by Major Types

• 3.4.1 Market Size and Growth Rate of Breast Cancer

• 3.4.2 Market Size and Growth Rate of Blood Cancer

• 3.4.3 Market Size and Growth Rate of Gastrointestinal Cancer

• 3.4.4 Market Size and Growth Rate of Prostate Cancer

• 3.4.5 Market Size and Growth Rate of Skin Cancer

• 3.4.6 Market Size and Growth Rate of Lung Cancer

4 Segmentation of Cancer Drugs Market by End-Users

• 4.1 Downstream Client Analysis by End-Users

• 4.2 Competitive Landscape Analysis of Different End-Users

• 4.3 Market Potential Analysis of Different End-Users

• 4.4 Market Size of Cancer Drugs by Major End-Users

• 4.4.1 Market Size and Growth Rate of Cancer Drugs in Immunotherapy

• 4.4.2 Market Size and Growth Rate of Cancer Drugs in Targeted Therapy

• 4.4.3 Market Size and Growth Rate of Cancer Drugs in Chemotherapy

• 4.4.4 Market Size and Growth Rate of Cancer Drugs in Hormone Therapy

5 Market Analysis by Regions

• 5.1 Japan Cancer Drugs Production Analysis by Regions

• 5.2 Japan Cancer Drugs Consumption Analysis by Regions

6 Hokkaido Cancer Drugs Landscape Analysis

• 6.1 Hokkaido Cancer Drugs Landscape Analysis by Major Types

• 6.2 Hokkaido Cancer Drugs Landscape Analysis by Major End-Users

7 Tohoku Cancer Drugs Landscape Analysis

• 7.1 Tohoku Cancer Drugs Landscape Analysis by Major Types

• 7.2 Tohoku Cancer Drugs Landscape Analysis by Major End-Users

8 Kanto Cancer Drugs Landscape Analysis

• 8.1 Kanto Cancer Drugs Landscape Analysis by Major Types

• 8.2 Kanto Cancer Drugs Landscape Analysis by Major End-Users

9 Chubu Cancer Drugs Landscape Analysis

• 9.1 Chubu Cancer Drugs Landscape Analysis by Major Types

• 9.2 Chubu Cancer Drugs Landscape Analysis by Major End-Users

10 Kinki Cancer Drugs Landscape Analysis

• 10.1 Kinki Cancer Drugs Landscape Analysis by Major Types

• 10.2 Kinki Cancer Drugs Landscape Analysis by Major End-Users

11 Chugoku Cancer Drugs Landscape Analysis

• 11.1 Chugoku Cancer Drugs Landscape Analysis by Major Types

• 11.2 Chugoku Cancer Drugs Landscape Analysis by Major End-Users

12 Shikoku Cancer Drugs Landscape Analysis

• 12.1 Shikoku Cancer Drugs Landscape Analysis by Major Types

• 12.2 Shikoku Cancer Drugs Landscape Analysis by Major End-Users

13 Kyushu Cancer Drugs Landscape Analysis

• 13.1 Kyushu Cancer Drugs Landscape Analysis by Major Types

• 13.2 Kyushu Cancer Drugs Landscape Analysis by Major End-Users

14 Major Players Profiles

• 14.1 Bristol-Myers Squibb
  

• 14.1.1 Bristol-Myers Squibb Company Profile and Recent Development

• 14.1.2 Market Performance

• 14.1.3 Product and Service Introduction

• 14.2 Ariad Pharmaceuticals
  

• 14.2.1 Ariad Pharmaceuticals Company Profile and Recent Development

• 14.2.2 Market Performance

• 14.2.3 Product and Service Introduction

• 14.3 GlaxoSmithKline
  

• 14.3.1 GlaxoSmithKline Company Profile and Recent Development

• 14.3.2 Market Performance

• 14.3.3 Product and Service Introduction

• 14.4 Amgen
  

• 14.4.1 Amgen Company Profile and Recent Development

• 14.4.2 Market Performance

• 14.4.3 Product and Service Introduction

• 14.5 Johnson and Johnson
  

• 14.5.1 Johnson and Johnson Company Profile and Recent Development

• 14.5.2 Market Performance

• 14.5.3 Product and Service Introduction

• 14.6 Novartis
  

• 14.6.1 Novartis Company Profile and Recent Development

• 14.6.2 Market Performance

• 14.6.3 Product and Service Introduction

• 14.7 Eli Lilly
  

• 14.7.1 Eli Lilly Company Profile and Recent Development

• 14.7.2 Market Performance

• 14.7.3 Product and Service Introduction

• 14.8 Bayer
  

• 14.8.1 Bayer Company Profile and Recent Development

• 14.8.2 Market Performance

• 14.8.3 Product and Service Introduction

• 14.9 Teva Pharmaceuticals
  

• 14.9.1 Teva Pharmaceuticals Company Profile and Recent Development

• 14.9.2 Market Performance

• 14.9.3 Product and Service Introduction

• 14.10 Sanofi and Pfizer
  

• 14.10.1 Sanofi and Pfizer Company Profile and Recent Development

• 14.10.2 Market Performance

• 14.10.3 Product and Service Introduction

• 14.11 Boehringer Ingelheim
  

• 14.11.1 Boehringer Ingelheim Company Profile and Recent Development

• 14.11.2 Market Performance

• 14.11.3 Product and Service Introduction

• 14.12 Celgene Corporation
  

• 14.12.1 Celgene Corporation Company Profile and Recent Development

• 14.12.2 Market Performance

• 14.12.3 Product and Service Introduction

• 14.13 Hoffmann-La Roche
  

• 14.13.1 Hoffmann-La Roche Company Profile and Recent Development

• 14.13.2 Market Performance

• 14.13.3 Product and Service Introduction

• 14.14 Merck
  

• 14.14.1 Merck Company Profile and Recent Development

• 14.14.2 Market Performance

• 14.14.3 Product and Service Introduction

The List of Tables and Figures (Totals 115 Figures and 172 Tables)

• Figure Japan Cancer Drugs Market Size and Growth Rate of Breast Cancer from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Blood Cancer from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Gastrointestinal Cancer from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Prostate Cancer from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Skin Cancer from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Lung Cancer from 2014 to 2026

• Figure Market Share by Type in 2014

• Figure Market Share by Type in 2018

• Figure Market Share by Type in 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Hormone Therapy from 2014 to 2026

• Figure Market Share by End-User in 2014

• Figure Market Share by End-User in 2018

• Figure Market Share by End-User in 2026

• Figure Hokkaido Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Tohoku Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kanto Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chubu Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kinki Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chugoku Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Shikoku Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kyushu Cancer Drugs Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Development Trends and Industry Dynamics of Cancer Drugs Industry

• Figure Market Challenges and Restraints

• Figure Market Opportunities and Potentials

• Table Mergers and Acquisition

• Figure Market Share of TOP 3 Players in 2018

• Figure Market Share of TOP 5 Players in 2018

• Figure Market Share of TOP 6 Players from 2014 to 2019

• Figure Porter's Five Forces Analysis

• Figure New Entrant SWOT Analysis

• Table Specifications of Different Types of Cancer Drugs

• Figure Development Trends of Different Types

• Table Commercial Products Types of Major Vendors

• Figure Competitive Landscape Analysis of Different Types

• Table Consumption of Cancer Drugs by Different Types from 2014 to 2026

• Table Consumption Share of Cancer Drugs by Different Types from 2014 to 2026

• Figure Market Size and Growth Rate of Breast Cancer

• Figure Market Size and Growth Rate of Blood Cancer

• Figure Market Size and Growth Rate of Gastrointestinal Cancer

• Figure Market Size and Growth Rate of Prostate Cancer

• Figure Market Size and Growth Rate of Skin Cancer

• Figure Market Size and Growth Rate of Lung Cancer

• Table Downstream Client Analysis by End-Users

• Figure Competitive Landscape Analysis of Different End-Users

• Table Market Potential Analysis of Different End-Users

• Table Consumption of Cancer Drugs by Different End-Users from 2014 to 2026

• Table Consumption Share of Cancer Drugs by Different End-Users from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Immunotherapy from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Targeted Therapy from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Chemotherapy from 2014 to 2026

• Figure Japan Cancer Drugs Market Size and Growth Rate of Hormone Therapy from 2014 to 2026

• Table Japan Cancer Drugs Production by Regions

• Table Japan Cancer Drugs Production Share by Regions

• Figure Japan Cancer Drugs Production Share by Regions in 2014

• Figure Japan Cancer Drugs Production Share by Regions in 2018

• Figure Japan Cancer Drugs Production Share by Regions in 2026

• Table Japan Cancer Drugs Consumption by Regions

• Table Japan Cancer Drugs Consumption Share by Regions

• Figure Japan Cancer Drugs Consumption Share by Regions in 2014

• Figure Japan Cancer Drugs Consumption Share by Regions in 2018

• Figure Japan Cancer Drugs Consumption Share by Regions in 2026

• Table Hokkaido Cancer Drugs Consumption by Types from 2014 to 2026

• Table Hokkaido Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Hokkaido Cancer Drugs Consumption Share by Types in 2014

• Figure Hokkaido Cancer Drugs Consumption Share by Types in 2018

• Figure Hokkaido Cancer Drugs Consumption Share by Types in 2026

• Table Hokkaido Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Hokkaido Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Hokkaido Cancer Drugs Consumption Share by End-Users in 2014

• Figure Hokkaido Cancer Drugs Consumption Share by End-Users in 2018

• Figure Hokkaido Cancer Drugs Consumption Share by End-Users in 2026

• Table Tohoku Cancer Drugs Consumption by Types from 2014 to 2026

• Table Tohoku Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Tohoku Cancer Drugs Consumption Share by Types in 2014

• Figure Tohoku Cancer Drugs Consumption Share by Types in 2018

• Figure Tohoku Cancer Drugs Consumption Share by Types in 2026

• Table Tohoku Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Tohoku Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Tohoku Cancer Drugs Consumption Share by End-Users in 2014

• Figure Tohoku Cancer Drugs Consumption Share by End-Users in 2018

• Figure Tohoku Cancer Drugs Consumption Share by End-Users in 2026

• Table Kanto Cancer Drugs Consumption by Types from 2014 to 2026

• Table Kanto Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Kanto Cancer Drugs Consumption Share by Types in 2014

• Figure Kanto Cancer Drugs Consumption Share by Types in 2018

• Figure Kanto Cancer Drugs Consumption Share by Types in 2026

• Table Kanto Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Kanto Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Kanto Cancer Drugs Consumption Share by End-Users in 2014

• Figure Kanto Cancer Drugs Consumption Share by End-Users in 2018

• Figure Kanto Cancer Drugs Consumption Share by End-Users in 2026

• Table Chubu Cancer Drugs Consumption by Types from 2014 to 2026

• Table Chubu Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Chubu Cancer Drugs Consumption Share by Types in 2014

• Figure Chubu Cancer Drugs Consumption Share by Types in 2018

• Figure Chubu Cancer Drugs Consumption Share by Types in 2026

• Table Chubu Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Chubu Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Chubu Cancer Drugs Consumption Share by End-Users in 2014

• Figure Chubu Cancer Drugs Consumption Share by End-Users in 2018

• Figure Chubu Cancer Drugs Consumption Share by End-Users in 2026

• Table Kinki Cancer Drugs Consumption by Types from 2014 to 2026

• Table Kinki Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Kinki Cancer Drugs Consumption Share by Types in 2014

• Figure Kinki Cancer Drugs Consumption Share by Types in 2018

• Figure Kinki Cancer Drugs Consumption Share by Types in 2026

• Table Kinki Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Kinki Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Kinki Cancer Drugs Consumption Share by End-Users in 2014

• Figure Kinki Cancer Drugs Consumption Share by End-Users in 2018

• Figure Kinki Cancer Drugs Consumption Share by End-Users in 2026

• Table Chugoku Cancer Drugs Consumption by Types from 2014 to 2026

• Table Chugoku Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Chugoku Cancer Drugs Consumption Share by Types in 2014

• Figure Chugoku Cancer Drugs Consumption Share by Types in 2018

• Figure Chugoku Cancer Drugs Consumption Share by Types in 2026

• Table Chugoku Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Chugoku Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Chugoku Cancer Drugs Consumption Share by End-Users in 2014

• Figure Chugoku Cancer Drugs Consumption Share by End-Users in 2018

• Figure Chugoku Cancer Drugs Consumption Share by End-Users in 2026

• Table Shikoku Cancer Drugs Consumption by Types from 2014 to 2026

• Table Shikoku Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Shikoku Cancer Drugs Consumption Share by Types in 2014

• Figure Shikoku Cancer Drugs Consumption Share by Types in 2018

• Figure Shikoku Cancer Drugs Consumption Share by Types in 2026

• Table Shikoku Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Shikoku Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Shikoku Cancer Drugs Consumption Share by End-Users in 2014

• Figure Shikoku Cancer Drugs Consumption Share by End-Users in 2018

• Figure Shikoku Cancer Drugs Consumption Share by End-Users in 2026

• Table Kyushu Cancer Drugs Consumption by Types from 2014 to 2026

• Table Kyushu Cancer Drugs Consumption Share by Types from 2014 to 2026

• Figure Kyushu Cancer Drugs Consumption Share by Types in 2014

• Figure Kyushu Cancer Drugs Consumption Share by Types in 2018

• Figure Kyushu Cancer Drugs Consumption Share by Types in 2026

• Table Kyushu Cancer Drugs Consumption by End-Users from 2014 to 2026

• Table Kyushu Cancer Drugs Consumption Share by End-Users from 2014 to 2026

• Figure Kyushu Cancer Drugs Consumption Share by End-Users in 2014

• Figure Kyushu Cancer Drugs Consumption Share by End-Users in 2018

• Figure Kyushu Cancer Drugs Consumption Share by End-Users in 2026

• Table Company Profile and Development Status of Bristol-Myers Squibb

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

• Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

• Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

• Table Product and Service Introduction of Bristol-Myers Squibb

• Table Company Profile and Development Status of Ariad Pharmaceuticals

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ariad Pharmaceuticals

• Figure Sales and Growth Rate Analysis of Ariad Pharmaceuticals

• Figure Revenue and Market Share Analysis of Ariad Pharmaceuticals

• Table Product and Service Introduction of Ariad Pharmaceuticals

• Table Company Profile and Development Status of GlaxoSmithKline

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

• Figure Sales and Growth Rate Analysis of GlaxoSmithKline

• Figure Revenue and Market Share Analysis of GlaxoSmithKline

• Table Product and Service Introduction of GlaxoSmithKline

• Table Company Profile and Development Status of Amgen

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

• Figure Sales and Growth Rate Analysis of Amgen

• Figure Revenue and Market Share Analysis of Amgen

• Table Product and Service Introduction of Amgen

• Table Company Profile and Development Status of Johnson and Johnson

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson

• Figure Sales and Growth Rate Analysis of Johnson and Johnson

• Figure Revenue and Market Share Analysis of Johnson and Johnson

• Table Product and Service Introduction of Johnson and Johnson

• Table Company Profile and Development Status of Novartis

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

• Figure Sales and Growth Rate Analysis of Novartis

• Figure Revenue and Market Share Analysis of Novartis

• Table Product and Service Introduction of Novartis

• Table Company Profile and Development Status of Eli Lilly

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

• Figure Sales and Growth Rate Analysis of Eli Lilly

• Figure Revenue and Market Share Analysis of Eli Lilly

• Table Product and Service Introduction of Eli Lilly

• Table Company Profile and Development Status of Bayer

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

• Figure Sales and Growth Rate Analysis of Bayer

• Figure Revenue and Market Share Analysis of Bayer

• Table Product and Service Introduction of Bayer

• Table Company Profile and Development Status of Teva Pharmaceuticals

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals

• Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals

• Figure Revenue and Market Share Analysis of Teva Pharmaceuticals

• Table Product and Service Introduction of Teva Pharmaceuticals

• Table Company Profile and Development Status of Sanofi and Pfizer

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi and Pfizer

• Figure Sales and Growth Rate Analysis of Sanofi and Pfizer

• Figure Revenue and Market Share Analysis of Sanofi and Pfizer

• Table Product and Service Introduction of Sanofi and Pfizer

• Table Company Profile and Development Status of Boehringer Ingelheim

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

• Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

• Figure Revenue and Market Share Analysis of Boehringer Ingelheim

• Table Product and Service Introduction of Boehringer Ingelheim

• Table Company Profile and Development Status of Celgene Corporation

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

• Figure Sales and Growth Rate Analysis of Celgene Corporation

• Figure Revenue and Market Share Analysis of Celgene Corporation

• Table Product and Service Introduction of Celgene Corporation

• Table Company Profile and Development Status of Hoffmann-La Roche

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche

• Figure Sales and Growth Rate Analysis of Hoffmann-La Roche

• Figure Revenue and Market Share Analysis of Hoffmann-La Roche

• Table Product and Service Introduction of Hoffmann-La Roche

• Table Company Profile and Development Status of Merck

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

• Figure Sales and Growth Rate Analysis of Merck

• Figure Revenue and Market Share Analysis of Merck

• Table Product and Service Introduction of Merck